Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... development prior to initiating clinical trials. Aduro anticipates filing an investigational new drug (IND) application with the FDA in fourth quarter of 2010 to begin Phase 1 ...
2009 NOV 23 ... open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with ...
2009 NOV 23 ... 33 countries worldwide in this clinical research effort. MAGE-A3 ASCI is an investigational compound and it is not approved for use in any indication in any country at this time. ... Ecology, Environment, Chemotherapy, Clinical Research, Clinical Trial Research, Drug Therapy, Immunotherapy, Infectious Disease, Lung Neoplasms, Non-Small Cell Lung Cancer, ...
2009 NOV 23 ... the veterans screening program is the first large-scale study of Biomoda's CyPath® investigational use (not yet FDA-approved) diagnostic, which is based on a patented molecular marker ... FDA, Lung Cancer, Lung Neoplasms, Oncology, Regulatory Actions, U.S. Food and Drug Administration, Biomoda Inc. This article was prepared by Biotech Business ...
2009 NOV 23 ... direct an immune response against specific disease epitopes. In the case of CEL-SCI's investigational LEAPS-H1N1 treatment, this involves non-changing regions of H1N1 Pandemic Flu, Avian Flu ... www.cel-sci.com Keywords: AIDS, Acquired Immunodeficiency Syndrome, Adverse Drug Reaction, Arthritis, Biotechnology, Cancer Vaccines, Cytokines, Genetics, H1N1 Virus, ...
2009 NOV 23 ... to prevent and treat human disease, has announced that it has filed its first IND (investigational new drug) application with the U.S. Food and Drug Administration (FDA). CEQ508, an ...
2009 NOV 23 ... Inc. announced that it has initiated a Phase 1b clinical study with CTP-518, its investigational oral HIV protease inhibitor for the treatment of HIV infection. In connection with the ... once-daily therapy without the side effects, inconvenience and expense of an additional drug." The initial Phase 1 clinical trial is designed to evaluate the safety, ...
2009 NOV 23 ... D-Pharm for treatment of patients with acute ischemic stroke. DP-b99, designated as an Investigational New Drug (IND) in the US, is currently in a Phase III multinational clinical study ...
2009 NOV 23 ... combined with a detailed tracking of key regulatory designations and events, from Investigational New Drug (IND) filing dates to FDA 'Fast Track' and orphan drug status designations, ...
2009 NOV 28 ... to the successful completion of ongoing GLP studies, believe we are on track to file an investigational new drug application and initiate a Phase I clinical trial of INX-189 in the first half ...
2009 NOV 23 ... Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) announced that the company's investigational new drug, LX1031, a tryptophan hydroxylase (TPH) inhibitor, demonstrated positive ...
2009 NOV 23 ... of respiratory syncytial virus (RSV) from ViroPharma Incorporated (Exton, PA). The lead investigational compound in the portfolio is an inhalable small molecule fusion inhibitor, now called ... products that address large market opportunities and are enabled by our game-changing drug delivery technologies. The acquisition of ViroPharma's portfolio is a perfect fit with ...
2009 NOV 23 ... Effects in Animal Models of Asthma". DAS181 (Fludase=AE) is an investigational broad spectrum host-targeting drug candidate being studied in human clinical development ...
2009 NOV 23 ... was needed, and the other strategy tested the potential benefits and risks of an investigational device to maintain pressure in the chest during CPR. After reviewing data ... without adverse effects. A modified version of the ITD is approved by the Food and Drug Administration (FDA) for use in conditions other than cardiac arrest. ...
Subject: NIH/National Heart, Lung and Blood Institute
2009 NOV 23 ... "enrolled in this phase II, noncomparative, multicenter trial were naive to the investigational drugs and had plasma HIV RNA levels >1000 copies/mL, a history of virologic failure ... Syndrome, Antivirals, Biotechnology Business, Biotechnology Company, Darunavir, Drug Resistance, Drugs, Enzymes, Etravirine, Fusion Inhibitor, HIV, Human Immunodeficiency ...
2009 NOV 23 ... that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Sol-Gel's Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea. This ...
2009 NOV 23 ... SpinalMotion, developer of the investigational Kineflex® lumbar and Kineflex/C® cervical disc implants for treating patients ... Trial Research, Degenerative Disc Disease, FDA, Regulatory Actions, U.S. Food and Drug Administration, SpinalMotion. This article was prepared by Pain & Central ...
2009 NOV 23 ... reduction in prostate-specific antigen (PSA) levels. Notably, TOK-001 is the first investigational new drug that decreases androgen receptor levels in prostate cancer cells and the only ...
2009 NOV 23 ... half of 2010. An oral form of palifosfamide has been developed preclinically to the investigational new drug application stage. Darinaparsin (ZinaparTM or ZIO-101) is a novel ...
2009 NOV 23 ... half of 2010. An oral form of palifosfamide has been developed preclinically to the investigational new drug application stage. Darinaparsin (ZinaparTM or ZIO-101) is a novel ...
